Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant
The first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1990/917057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832545751990796288 |
|---|---|
| author | H Amin T Jadavji R Sauve J Gill |
| author_facet | H Amin T Jadavji R Sauve J Gill |
| author_sort | H Amin |
| collection | DOAJ |
| description | The first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days was given without adverse clinical or toxic effects. The patient has remained well following discharge from hospital. |
| format | Article |
| id | doaj-art-f2336e9040c749ba930dce3480e17902 |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 1990-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-f2336e9040c749ba930dce3480e179022025-02-03T07:24:58ZengWileyCanadian Journal of Infectious Diseases1180-23321990-01-0111283010.1155/1990/917057Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm InfantH Amin0T Jadavji1R Sauve2J Gill3Departments of Pediatrics, Microbiology and Infectious Disease. Foothills Hospital, The University of Calgary, Alberta, CanadaDepartments of Pediatrics, Microbiology and Infectious Disease. Foothills Hospital, The University of Calgary, Alberta, CanadaDepartments of Pediatrics, Microbiology and Infectious Disease. Foothills Hospital, The University of Calgary, Alberta, CanadaDepartments of Pediatrics, Microbiology and Infectious Disease. Foothills Hospital, The University of Calgary, Alberta, CanadaThe first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days was given without adverse clinical or toxic effects. The patient has remained well following discharge from hospital.http://dx.doi.org/10.1155/1990/917057 |
| spellingShingle | H Amin T Jadavji R Sauve J Gill Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant Canadian Journal of Infectious Diseases |
| title | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant |
| title_full | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant |
| title_fullStr | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant |
| title_full_unstemmed | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant |
| title_short | Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant |
| title_sort | use of ganciclovir in the treatment of acquired cytomegalovirus disease in a preterm infant |
| url | http://dx.doi.org/10.1155/1990/917057 |
| work_keys_str_mv | AT hamin useofganciclovirinthetreatmentofacquiredcytomegalovirusdiseaseinapreterminfant AT tjadavji useofganciclovirinthetreatmentofacquiredcytomegalovirusdiseaseinapreterminfant AT rsauve useofganciclovirinthetreatmentofacquiredcytomegalovirusdiseaseinapreterminfant AT jgill useofganciclovirinthetreatmentofacquiredcytomegalovirusdiseaseinapreterminfant |